Dissertation > Excellent graduate degree dissertation topics show

Studies on Regulation Effects and Mechanism of Turochenodeoxycholic Acid Immunologic Function in Mice

Author: ShiYouZuo
Tutor: LiPeiFeng
School: Inner Mongolia Agricultural University
Course: Basic Veterinary Science
Keywords: Taurochenodeoxycholic Acid Peritoneal Macrophage SplenicLymphocyte Low Immunological Function Mice Model Nerves-Endocrine- Immunomodulation system Immunomodulation
CLC: R392
Type: PhD thesis
Year: 2007
Downloads: 285
Quote: 3
Read: Download Dissertation

Abstract


Taurochenodeoxycholic Acid(TCDCA)is one of main active components in animal biliary,its chemical name is 3α,7α-dioxy-5β-24-cholane-oyl-N- Taurine, which is an acor-compound combined from Taurine and Chenocholic acid. This topic systematically studied on immunological regulation effects of TCDCA, and intended to approach the immunological regulation effects and mechanism of TCDCA on normal and low immune function mice organisms. Then the main contents include:(1)We detected the effects of TCDCA on mice peritoneal macrophage phagocytosis、peripheral blood IL-1βand IgG contents、spleen IL-2 genetic expression by chicken red blood cell demi-intracorporal method、ELISA method and actual time fluorescent quantitation PCR technique. The experimental results showed: According to 0.1g/kg·b·w , peroral administration of TCDCA can extremely elevate the phagocytosis of mice peritoneal macrophage, and achieve the maximum effective strength; can significantly elevate peripheral blood IL-1βand IgG contents; can elevate spleen IL-2 expressional quantity; according to 0.153g/kg·b·w and 0.189g/kg·b·w , administration of TCDCA all can significantly restrain the phagocytosis of mice peritoneal macrophage, degrade spleen IL-2 expressional quantity; and when TCDCA dosage reach 0.189g/kg·b·w, also can significantly restrain peripheral blood IgG contents. So, indicated that normal organism immunomodulation effect of TCDCA has close relationship with its dosage, and between 0.043~0.1g/kg·b·w, show enhancement property on organism specificity and non-specificity immunologic functions. When dosage is 0.1g/kg·b·w,the effect is most strong and more than 0.1g/kg·b·w, immunifaction begin to weaken, even create the inhibitory action.(2)We also detected the effects of TCDCA and metabolic products CDCA and Tau on culturing in vitro mice peritoneal macrophage and splenic lymphocyte proliferative response、cytokine secretion et al immunological functions by using MTT method、phagocytose neutral red method、ELISA method. The experimental results showed:①When final concentrations were 0.01、1 and 10μg/ml, TCDCA had the prominent enhancement property on normal peritoneal macrophage proliferative response and had the prominent synergistic effect on LPS induced proliferative response. When final concentrations were 0.01、0.05 and 1μg/ml, TCDCA had the prominent enhancement property on peritoneal macrophage excrete IL-1βand when 0.01μg/ml, TCDCA had the prominent synergistic effect on LPS induced peritoneal macrophage excrete IL-1β, and when 1μg/ml, TCDCA had the prominent inhibitory action on LPS irritant peritoneal macrophage excrete IL-1β. TCDCA had un-significant effect on normal peritoneal macrophage phagocytosis.②When final concentrations were 0.1 and 1μg/ml, TCDCA had the prominent enhancement property on splenic lymphocyte proliferative response, and when 0.1μg/ml, TCDCA had the prominent antagonistic effect on ConA irritant proliferative response. TCDCA had un-significant effect on all LPS and CsA irritant splenic lymphocyte proliferative response. When final concentrations was 0.01μg/ml, TCDCA had the prominent enhancement property on splenic lymphocyte excrete IL-2, and TCDCA had un-significant effect on ConA irritant splenic lymphocyte excrete IL-2. When final concentrations was 0.01μg/ml, TCDCA had the prominent synergistic effect on LPS induced splenic lymphocyte excrete IL-2, and when 0.05μg/ml, TCDCA had the prominent antagonistic effect on LPS induced splenic lymphocyte excrete IL-2, When 0.01μg/ml, TCDCA had the prominent coordinate repression on CsA inhibitive splenic lymphocyte excrete IL-2. When final concentrations were 0.01 and 0.05μg/ml, TCDCA had the prominent enhancement property on splenic lymphocyte excrete IgG, and when 0.05 and 0.1μg/ml, TCDCA had the prominent synergistic effect on LPS induced splenic lymphocyte excrete IgG.③When final concentrations were 0.5 and 5μg/ml, CDCA and Tau had un-significant effects on all normal and suboptimal dose LPS irritant peritoneal macrophage、splenic lymphocyte proliferative response and splenic lymphocyte excrete IgG, but had the prominent enhancement property on normal peritoneal macrophage excrete IL-1β.When final concentration was 5μg/ml, CDCA had the prominent enhancement property on peritoneal macrophage phagocytosis and Tau had the prominent inhibitory action on peritoneal macrophage phagocytosis. When final concentration was 0.5μg/ml, CDCA had the prominent enhancement property on normal splenic lymphocyte excrete IL-2. When final concentrations were 0.5 and 5μg/ml, Tau had the prominent or extremely prominent enhancement property on either normal or ConA、LPS irritant splenic lymphocyte excrete IL-2 and when 0.5μg/ml, Tau had the prominent reablement effect on CsA inhibitive IL-2 excreting.(3)We evaluated the effects of TCDCA on CTX and CsA prepared lower nonspecific and specific immunological function mice model. The results showed: According to 0.1g/kg·b·w , peroral administration of TCDCA had the prominent enhancement or reablement effects all on lower nonspecific immunity function model mice peritoneal macrophage phagocytosis and lower specific immunity function model mice peripheral blood IgG.(4) We analyzed the vivo metabolism control lattice of TCDCA, predicted effects of this medicine on nerves-endocrine-immunomodulation system, moreover, detected the contents of hydrocortisone in post- administration mice blood serum by utilizing radio-immunity method. The results showed: According to 0.1g/kg·b·w , peroral administration of TCDCA had the extremely prominent enhancement property on hydrocortisone contents in mice neuro- humor-immunomodulation system.These chief conclusions below are yielded from this experimental study:(1)The optimization dosage of TCDCA on enhancing mice immunologic function is 0.1g/kg.(2)Either on nonspecific immunity function or specific cellular immunity、humoral immune function of mice organism, TCDCA all showed the prominent dose dependent two-way immunomodulation effect.(3)Either on normal mice organism or low immunologic function mice, TCDCA all had evident immunomodulation effects.(4)The regulation effect of TCDCA on mice organism immunological function is the results of TCDCA and its metabolites CDCA and Tau directly affect together on immunocell and produce influence on organism neuro-humor-immunomodulation system.

Related Dissertations

  1. Effects of Taurochenodeoxycholic Acid on Heat-stressed Mice,S858.91
  2. Effects of TCDCA on Apoptosis of Immunocytes in Mice,R392
  3. Experimental Study on Enhancing the Antihepatoma Immunity Mediated by Dendritic Cells and Their Related Exosomes,R735.7
  4. Of Shugan Law immune hepatic fibrosis in rat cells extracellular matrix metabolism and immune regulation mechanism,R259.7
  5. The Cellular Bases of Brain Lateralization Affecting Neuroimmunoendocrine,R392
  6. Clinical and Experimental Study on the Immune Regulation Effect of Chuankezhi Injection in Asthma,R285
  7. Proliferation, Differentiation and Immune Inhibitory Ability of Immune Cells of Mice Stimulated by Adult Worm Antigen and Egg Antigen of Schistosoma Japonicum,R392
  8. The Study on the Role of Steroid Receptor Coactivator-3 in Inflammatory/immune Response,R363
  9. Total Synthesis of a Novel Marine Derived α-Galactoglycosphingolipid Clarhamnoside and Study on the Syntheses of Several Analogues of KRN7000,R914
  10. The the waterline grass pharmacological effects and its related substances basic research,R285.5
  11. Effects of Donor Kupffer Cell Modulation on Allograft Function and Acute Rejection after Liver Transplantation in the Rat,R657.3
  12. The Effect of Head & Neck Squamous Cell Carcinoma on the Expression of Toll-like Receptor 3 in Human Natural Killer Cell,R739.91
  13. Study on Effects of PAP on Immunomodulation and Anti-oxidation,S853.7
  14. Antitumor and Mechanism of Thalidomide,R730.5
  15. Experimental Studies on the Biological Characteristics and Immunomodulatory Activities of Mesenchymal Stem Cells Modified by Hepatocyte Growth Factor Gene,R346
  16. Studies on Effect of Selenium on Chicken’s Resistance to Marek’s Disease and Its Mechanism,S858.31
  17. Anti-thrombotic and Anti-tumoral Effects of Cinnamaldehyde in Vivo,R285
  18. Studies on Biological Properties and Probiotic Effects of Lactobacilli from Traditional Dairy Products in Inner Mongolia,R151
  19. Expression and Characteristic Analysis of Synthetic Human Epidermal Growth Factor and Fungal Immunomodulate Protein in Transgenic Tobacco Plant,Q943.2
  20. Purification and Immunomodulating Activities of Polysaccharide from Angelica Sinensis,R285

CLC: > Medicine, health > Basic Medical > Medical Immunology
© 2012 www.DissertationTopic.Net  Mobile